A Brighton Collaboration standardized template with key considerations for a benefit-risk assessment for the

Shanti Pather1, Nicola Charpentier1, Frank van den Ouweland1

  • 1BioNTech SE, Mainz, Germany.

Vaccine
|August 28, 2024
PubMed